Cencora INC CENCORA INC ORD SHS
Cencora INC CENCORA INC ORD SHS/ US03073E1055 /
0HF3
|
18.11.2024 19:06:31
|
Zm.
-
|
Wolumen |
Bid06:00:08 |
Ask06:00:08 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
243,20USD
|
-
|
1 931
Obrót: 466 807,31 |
-Wolumen Bid: - |
-Wolumen Ask: - |
47,86 mldUSD |
0,80% |
28,18 |
Opis działalności
Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
Zarząd & Rada nadzorcza
| CEO |
| Steven H. Collis |
| Zarząd |
| James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas |
| Rada nadzorcza |
| Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D. |
Dane firmy
| Nazwa: |
Cencora Inc |
| Adres: |
1 West First Avenue,Conshohocken, PA 19428-1800, USA |
| Telefon: |
+1-610-727-7000 |
| Fax: |
+1-800-640-5221 |
| E-mail: |
InvestorRelations@cencora.com
|
| Internet: |
https://www.cencora.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
30.09 |
| Free float: |
55,10% |
| Data IPO: |
04.04.1995 |
Główni akcjonariusze
| Inne |
|
58,24% |
| Vanguard Group |
|
10,28% |
| BlackRock Inc. |
|
9,86% |
| PRICE T ROWE ASSOCIATES INC MD |
|
5,36% |
| State Street Corporation |
|
3,95% |
| JP Morgan Chase & Co. |
|
2,73% |
| FMR LLC. |
|
2,31% |
| Boston Partners |
|
2,02% |
| Wellington Management Group |
|
1,90% |
| Inne |
|
3,35% |
